pac.dog pac.dog /orgs

OTSUKA AMERICA PHARMACEUTICAL, INC.

Sign in to add to a watchlist →

lobbying_firm · US · canonical: otsuka america pharmaceutical · 2 aliases · 1 outbound · 4 inbound

Activity

Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.

  1. 2026-05-18 · lobbied by Bert Steele · lda_lobbyist_client
  2. 2026-05-18 · employs Amelia Suermann · lda_lobbyist_firm
  3. 2026-05-18 · employs Isabel Omer · lda_lobbyist_firm
  4. 2026-05-18 · employs Thomas Foulkes · lda_lobbyist_firm
  5. 2026-01-01 · lobbies for OTSUKA AMERICA PHARMACEUTICAL, INC. $210,000 · lda_filing

Lobbying disclosures — as CLIENT (1)

Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.

PostedFilingYearPeriodRegistrant (lobbying firm)IncomeExpenses
2025-04-061st Quarter - Report2025first_quarter401103251$30,000

Lobbying disclosures — as REGISTRANT (1)

Filings where this org IS a lobbying firm hired by another entity.

PostedFilingYearPeriodClientIncomeExpenses
2026-04-171st Quarter - Report2026first_quarter197760$210,000

Aliases (2)

sourceidname at sourcejurisdictionconfidencelinked bylinked at
lda_client58328OTSUKA AMERICA PHARMACEUTICAL, INC.USgoldsync_canonical_entities
lda_registrant401093052OTSUKA AMERICA PHARMACEUTICAL, INC.USgoldbackfill_0029

Outbound edges (1)

datetypetoamountrolesource
2026-01-01lobbies_forOTSUKA AMERICA PHARMACEUTICAL, INC.$210,000lda_filing

Inbound edges (4)

datefromtypeamountsource
Bert Steelelobbied_forlda_lobbyist_client
Thomas Foulkesworks_atlda_lobbyist_firm
Isabel Omerworks_atlda_lobbyist_firm
Amelia Suermannworks_atlda_lobbyist_firm

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.

Want to partner? Contact us.